Concepedia

Author

Akira Kagayama

Fujisawa City Hospital

Also Known As

A Kagayama, A. KAGAYAMA, A. Kagayama, AKIRA KAGAYAMA, Akira KAGAYAMA, Akira Kagayama

54

Publications

1.6K

Citations

21

H-Index

59

Concepts

All Affiliations

Fujisawa City HospitalKyoto UniversityNational Institute of Health SciencesMochida Pharmaceutical (Japan)Kyoto Pharmaceutical University
AK

About

Akira Kagayama is an author at Fujisawa City Hospital specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

14

611

2

Biochemistry

11

13

628

3

Engineering

10

10

323

4

Natural Sciences

8

8

269

5

Health Sciences

4

4

391

Akira Kagayama

×

36

Publications

1.5K

Citations

21

H-Index

YearCitations

Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans.

Y. Naritomi, Shigeyuki Terashita, Sumihisa Kimura,

PubMed

2001

317

Utility of Hepatocytes in Predicting Drug Metabolism: Comparison of Hepatic Intrinsic Clearance in Rats and Humans in Vivo and in Vitro

Yoichi Naritomi, Shigeyuki Terashita, Akira Kagayama,

Drug Metabolism and Disposition

2003

185

Vibrational spectra and intermolecular potential of the α-form crystal of glycine

Katsunosuke Machida, Akira Kagayama, Yutaka Saito,

Spectrochimica Acta Part A Molecular Spectroscopy

1977

80

Prevention of progressive joint destruction in collagen‐induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR255031

Takeshi Ishikawa, Fusako Nishigaki, Susumu Miyata,

British Journal of Pharmacology

2004

62

Tissue Distribution after Intravenous Dosing of Micafungin, an Antifungal Drug, to Rats

Toshiro Niwa, Yoshiko Yokota, Akira Tokunaga,

Biological and Pharmaceutical Bulletin

2004

54

Polarized Raman spectra and intermolecular potential of l-alanine crystal

Katsunosuke Machida, Akira Kagayama, Yutaka Saito,

Spectrochimica Acta Part A Molecular Spectroscopy

1978

52

Identification and relative contributions of human cytochrome P450 isoforms involved in the metabolism of glibenclamide and lansoprazole: evaluation of an approach based on the<i>in vitro</i>substrate disappearance rate

Y. Naritomi, Shigeyuki Terashita, Akira Kagayama

Xenobiotica

2004

51

Development of a Novel Drug Release System, Time-Controlled Explosion System(TES). II. Design of Multiparticulate TES and in Vitro Drug Release Properties.

Satoshi Ueda, Hisami Yamaguchi, Masateru Kotani,

Chemical and Pharmaceutical Bulletin

1994

48

Contribution of Human Hepatic Cytochrome P450 Isoforms to the Metabolism of Psychotropic Drugs

Toshiro Niwa, Toshifumi Shiraga, Ikuko Ishii,

Biological and Pharmaceutical Bulletin

2005

44

Oral Absorption of FK506 in Rats

Akira Kagayama, Sachiyo Tanimoto, Jiro Fujisaki,

Pharmaceutical Research

1993

41

Page 1